Notably, we confirmed in our study a prognostic benefit of FoxP3+ T cell infiltrates which stands in contrast to previous meta-analyses suggesting that tumor-infiltrating FoxP3+ T-cells are associated with poor clinical outcomes in solid cancers68,69. This evidence concerns the gene FOXP3 and neoplasm.